DENNIS R LEE
Vehicle Board in Norristown, PA
License number
Pennsylvania MV060280L
Category
Vehicle Board
Type
Vehicle Salesperson
Address
Address
Norristown, PA 19408
Personal information
See more information about DENNIS R LEE at radaris.comName
Address
Phone
429 N 13Th St APT 5C, Philadelphia, PA 19123
5706 Wynnefield Ave, Philadelphia, PA 19131
1338 New Rodgers Rd, Levittown, PA 19056
495 Railroad St, Grampian, PA 16838
6251 Webster St, Philadelphia, PA 19143
Professional information
See more information about DENNIS R LEE at trustoria.com
Acid And Ester Compounds And Methods Of Using The Same
Acid And Ester Compounds And Methods Of Using The Same
US Patent:
7560586, Jul 14, 2009
Filed:
Mar 26, 2003
Appl. No.:
10/508893
Inventors:
Scott K. Thompson - King of Prussia PA, US
Lara S. Kallander - King of Prussia PA, US
Chun Ma - Edgewater NJ, US
Joseph Marino - King of Prussia PA, US
Dennis Lee - King of Prussia PA, US
Lara S. Kallander - King of Prussia PA, US
Chun Ma - Edgewater NJ, US
Joseph Marino - King of Prussia PA, US
Dennis Lee - King of Prussia PA, US
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
C07C 229/00
US Classification:
560 42
Abstract:
Disclosed is a compound of having the formula:pharmaceutically acceptable salts or solvates thereof and pharmaceutical compositions containing the same, wherein the structural variables are as defined herein. The compounds, salts and solvates of this invention are useful as LXR agonists.
Indazolo-Tetrahydropyrimidine-Carboxamide Derivative Kinase Inhibitors
Indazolo-Tetrahydropyrimidine-Carboxamide Derivative Kinase Inhibitors
US Patent:
7560467, Jul 14, 2009
Filed:
Jun 18, 2004
Appl. No.:
10/560502
Inventors:
David Harold Drewry - Durham NC, US
Brian Evans - Stevenage, GB
Krista B. Goodman - King of Prussia PA, US
Darren Victor Steven Green - Stevenage, GB
David Kendall Jung - Durham NC, US
Dennis Lee - King of Prussia PA, US
Robert A. Stavenger - King of Prussia PA, US
Sjoerd Nocolaas Wadman - Obermorschwiller, FR
Brian Evans - Stevenage, GB
Krista B. Goodman - King of Prussia PA, US
Darren Victor Steven Green - Stevenage, GB
David Kendall Jung - Durham NC, US
Dennis Lee - King of Prussia PA, US
Robert A. Stavenger - King of Prussia PA, US
Sjoerd Nocolaas Wadman - Obermorschwiller, FR
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
C07D 403/12, A61K 31/416
US Classification:
514274, 544316
Abstract:
The present invention relates to indazolo-tetrahydropyrimidine-carboxamide derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such indazolo-tetrahydropyrimidine-carboxamide derivatives are useful in the treatment of diseases associated with inappropriate ROCK-1 kinase.
Preparation Of 1,6-Disubstituted Azabenzimidazoles As Kinase Inhibitors
Preparation Of 1,6-Disubstituted Azabenzimidazoles As Kinase Inhibitors
US Patent:
7547779, Jun 16, 2009
Filed:
Oct 6, 2004
Appl. No.:
10/574676
Inventors:
Dennis Lee - King of Prussia PA, US
Robert A. Stavenger - King of Prussia PA, US
Krista B. Goodman - King of Prussia PA, US
Mark A. Hilfiker - King of Prussia PA, US
Haifeng Cui - King of Prussia PA, US
Andrew Q. Viet - King of Prussia PA, US
Joseph P. Marino - King of Prussia PA, US
Robert A. Stavenger - King of Prussia PA, US
Krista B. Goodman - King of Prussia PA, US
Mark A. Hilfiker - King of Prussia PA, US
Haifeng Cui - King of Prussia PA, US
Andrew Q. Viet - King of Prussia PA, US
Joseph P. Marino - King of Prussia PA, US
Assignee:
Glaxo Group Limited - Greenford, Middlesex
International Classification:
C07D 413/00, C07D 401/00, C07D 471/02, C07D 491/02
US Classification:
544127, 544362, 546118
Abstract:
Novel inhibitors of Rho-kinases are disclosed.
Preparation Of 1,7-Disubstituted Azabensimidazoles As Kinase Inhibitors
Preparation Of 1,7-Disubstituted Azabensimidazoles As Kinase Inhibitors
US Patent:
2007012, May 31, 2007
Filed:
Oct 6, 2004
Appl. No.:
10/574675
Inventors:
Dennis Lee - King of Prussia PA, US
Robert Stavenger - King of Prussia PA, US
Krista Goodman - King of Prussia PA, US
Mark Hilfiker - King of Prussia PA, US
Haifeng Cui - King of Prussia PA, US
Joseph Marino - King of Prussia PA, US
Robert Stavenger - King of Prussia PA, US
Krista Goodman - King of Prussia PA, US
Mark Hilfiker - King of Prussia PA, US
Haifeng Cui - King of Prussia PA, US
Joseph Marino - King of Prussia PA, US
International Classification:
C07D 471/02, A61K 31/4745
US Classification:
514303000, 546117000
Abstract:
Novel inhibitors of Rho-kinases are disclosed.
Preparation Of 1,6,7-Trisubstituted Azabenzimidazoles As Kinase Inhibitors
Preparation Of 1,6,7-Trisubstituted Azabenzimidazoles As Kinase Inhibitors
US Patent:
2007000, Jan 4, 2007
Filed:
Oct 6, 2004
Appl. No.:
10/574652
Inventors:
Dennis Lee - King of Prussia PA, US
Robert Stravenger - King of Prussia PA, US
Robert Stravenger - King of Prussia PA, US
International Classification:
C07D 471/02, A61K 31/4745
US Classification:
514303000, 546117000
Abstract:
Novel inhibitors of Rho-kinases are disclosed.
Anti-Inflammatory Compounds
Anti-Inflammatory Compounds
US Patent:
5545669, Aug 13, 1996
Filed:
Jun 2, 1994
Appl. No.:
8/252717
Inventors:
Jerry L. Adams - King of Prussia PA
Ralph F. Hall - King of Prussia PA
Dennis Lee - King of Prussia PA
Ruth J. Mayer - King of Prussia PA
George L. Seibel - King of Prussia PA
Ralph F. Hall - King of Prussia PA
Dennis Lee - King of Prussia PA
Ruth J. Mayer - King of Prussia PA
George L. Seibel - King of Prussia PA
International Classification:
A61K 31195
US Classification:
514562
Abstract:
This invention relates to the novel compounds and pharmaceutical compositions of Formula (I).
This invention also relates to a method of treating or reducing inflammation in a mammal in need thereof, which comprises administering to said mammal an effective amount of a compound or composition of Formula (I).
Imidazopyridine Derivatives As Kinase Inhibitors
Imidazopyridine Derivatives As Kinase Inhibitors
US Patent:
7348339, Mar 25, 2008
Filed:
Mar 21, 2003
Appl. No.:
10/508760
Inventors:
Nicholas Bailey - Harlow, GB
Mark James Bamford - Harlow, GB
Haifeng Cui - King of Prussia PA, US
Stephen Garland - Harlow, GB
Krista B Goodman - King of Prussia PA, US
Mark A Hilfiker - King of Prussia PA, US
Dennis Lee - King of Prussia PA, US
Terence Aaron Panchal - Harlow, GB
Robert A Stavenger - King of Prussia PA, US
David Matthew Wilson - Harlow, GB
Jason Witherington - Harlow, GB
Mark James Bamford - Harlow, GB
Haifeng Cui - King of Prussia PA, US
Stephen Garland - Harlow, GB
Krista B Goodman - King of Prussia PA, US
Mark A Hilfiker - King of Prussia PA, US
Dennis Lee - King of Prussia PA, US
Terence Aaron Panchal - Harlow, GB
Robert A Stavenger - King of Prussia PA, US
David Matthew Wilson - Harlow, GB
Jason Witherington - Harlow, GB
Assignee:
Glaxo Group Limited - Greenford, Middlesex
International Classification:
A61K 31/44, A01N 43/42, C07D 265/30, C07D 295/00, C07D 498/02
US Classification:
514303, 546118, 546141, 544127, 5142342, 514307
Abstract:
A compound of the formula.
Chemical Compounds
Chemical Compounds
US Patent:
2008027, Nov 6, 2008
Filed:
Jan 28, 2005
Appl. No.:
10/597473
Inventors:
David Harold Drewry - Durham NC, US
David Kendall Jung - Durham NC, US
James Andrew Linn - Durham NC, US
Robert Neil Hunter - Durham NC, US
Dennis Lee - King of Prussia PA, US
Robert A. Stavenger - King of Prussia PA, US
Clark Sehon - King of Prussia PA, US
David Kendall Jung - Durham NC, US
James Andrew Linn - Durham NC, US
Robert Neil Hunter - Durham NC, US
Dennis Lee - King of Prussia PA, US
Robert A. Stavenger - King of Prussia PA, US
Clark Sehon - King of Prussia PA, US
International Classification:
A61K 31/4409, C07D 213/04, A61K 31/415, C07D 231/10, C07D 239/42, A61K 31/505, C07D 239/24, C07D 231/56, C07D 401/10
US Classification:
514256, 546337, 514357, 514406, 5483751, 544332, 514275, 544335, 544329, 5483625
Abstract:
There is provided compounds of Formula (I) and salts, solvates, and physiologically functional derivatives thereof:wherein R1 is hydrogen or Calkyl; n is 1, 2, 3 or 4; R2 is aryl, optionally substituted by one or two groups selected from the group consisting of halogen, hydroxy, cyano, Calkyl, Calkoxy, Calkanoyl, haloCalkyl, haloCalkoxy, aryl, aryloxy, Calkoxycarbonyl, Calkylsulfonyl and a group R3R4NSO(wherein R3 and R4 are independently hydrogen or Calkyl) and a 5- or 6-membered heteroaryl group; or n is 0 and R1 and R2, together with the nitrogen atom to which they are joined, form a 5- or 6-membered monocyclic heterocyclic ring or a 9- or 10-membered bicyclic heterocyclic ring wherein at least the ring which contains the nitrogen atom to which R1 and R2 are joined is non-aromatic, and wherein the 5- or 6-membered monocyclic heterocyclic ring or the 9- or 10-membered bicyclic heterocyclic ring is optionally substituted by one or two groups selected from the group consisting of halogen, hydroxy, cyano, oxo, Calkyl, Calkanoyl, Calkoxy, haloCalkyl, haloCalkoxy, aryl, aryloxy and Calkoxycarbonyl; and X is indazolyl, pyrazolyl or a group:wherein G is CH or N; and Yand Yare independently hydrogen, halogen and a group NR5R6 (wherein R5 and R6 are independently hydrogen, Calkyl or Calkenyl).
Compounds
Compounds
US Patent:
7592357, Sep 22, 2009
Filed:
Feb 18, 2005
Appl. No.:
10/589995
Inventors:
Dennis Lee - King of Prussia PA, US
Krista B. Goodman - King of Prussia PA, US
Krista B. Goodman - King of Prussia PA, US
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
A61K 31/4709, A61K 31/4439, C07D 401/12, C07D 401/14
US Classification:
514314, 514338, 546167, 5462757
Abstract:
Novel Inhibitors of Rho-kinases are disclosed.
Novel Compounds
Novel Compounds
US Patent:
2006020, Sep 14, 2006
Filed:
Jul 15, 2004
Appl. No.:
10/564451
Inventors:
Dennis Lee - King of Prussia PA, US
Joseph Marino - King of Prussia PA, US
Yongdong Zhao - King of Prussia PA, US
Joseph Marino - King of Prussia PA, US
Yongdong Zhao - King of Prussia PA, US
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
A61K 31/4196, A61K 31/41, A61K 31/4192, A61K 31/4178, A61K 31/405, A61K 31/381, A61K 31/343
US Classification:
514281000, 514381000, 514359000, 514383000, 514397000, 514443000, 514469000, 514419000
Abstract:
Compounds of the formula (I) are disclosed which are large conductance calcium activated potassium channel openers (BK channels openers) and are useful in the treatment of urinary tract disorders:
or a pharmaceutically acceptable salt thereof.